申请人:Eli Lilly and Company
公开号:US07176224B2
公开(公告)日:2007-02-13
Novel compounds that are modulators of PPAR receptors, and pharmaceutically acceptable salts, solvates and hydrates thereof, processes for making the compounds, pharmaceutical compositions containing the compounds, or pharmaceutically acceptable salts, solvates and hydrates thereof
小说化合物是PPAR受体调节剂,以及其药学上可接受的盐、溶剂和水合物,制备这些化合物的过程,含有这些化合物或其药学上可接受的盐、溶剂和水合物的药物组合物。